Thu, July 21, 2022
Wed, July 20, 2022
Tue, July 19, 2022

Steve Valiquette Maintained (TDOC) at Hold with Decreased Target to $42 on, Jul 20th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-42-on-jul-20th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Steve Valiquette of Barclays, Maintained "Teladoc Health, Inc." (TDOC) at Hold with Decreased Target from $45 to $42 on, Jul 20th, 2022.

Steve has made no other calls on TDOC in the last 4 months.



There are 14 other peers that have a rating on TDOC. Out of the 14 peers that are also analyzing TDOC, 10 agree with Steve's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Grossman of "Stifel" Maintained at Hold with Decreased Target to $36 on, Wednesday, June 29th, 2022
  • John Eade of "Argus Research" Downgraded from Strong Buy to Hold on, Thursday, May 5th, 2022
  • Jonathan Yong of "Credit Suisse" Downgraded from Buy to Hold and Decreased Target to $35 on, Thursday, April 28th, 2022
  • Matt Hewitt of "Craig-Hallum" Maintained at Hold with Decreased Target to $30 on, Thursday, April 28th, 2022
  • Ryan Daniels of "William Blair" Downgraded from Buy to Hold on, Thursday, April 28th, 2022
  • Sandy Draper of "Guggenheim" Downgraded from Strong Buy to Hold on, Thursday, April 28th, 2022
  • Stan Berenshteyn of "Wells Fargo" Downgraded from Buy to Hold and Held Target at $40 on, Thursday, April 28th, 2022
  • Stephanie Davis Demko of "SVB Leerink" Downgraded from Buy to Hold and Decreased Target to $35 on, Thursday, April 28th, 2022
  • Daniel Grosslight of "Citigroup" Downgraded from Strong Buy to Hold and Decreased Target to $43 on, Thursday, April 28th, 2022
  • George Hill of "Deutsche Bank" Maintained at Hold with Decreased Target to $44 on, Thursday, April 28th, 2022


These are the ratings of the 4 analyists that currently disagree with Steve


  • Cindy Motz of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $55 on, Thursday, May 26th, 2022
  • Richard Close of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $50 on, Thursday, April 28th, 2022
  • Ryan MacDonald of "Needham" Maintained at Strong Buy with Decreased Target to $48 on, Thursday, April 28th, 2022
  • Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $65 on, Thursday, April 28th, 2022

Publication Contributing Sources